Loading story…
(RTTNews) - Medicus Pharma Ltd. (MDCX), a clinical-stage biopharmaceutical company, announced that it has submitted an optimized Phase 2 study protocol to the U.S. FDA for Teverelix, its lead candidate in the treatment…
(RTTNews) - Medicus Pharma Ltd. (MDCX), a clinical-stage biopharmaceutical company, announced that it has submitted an optimized Phase 2 study protocol to the U.S. FDA for Teverelix, its lead candidate in the treatment of acute urinary retention.
Same desk, different stories
3 Energy Stocks to Buy as AI Power Demand Surges—and 2 to Avoid
LendingClub: A Digital Bank Growing Again Like a Fintech
3 Quiet Outperformers Boosting Dividends as Markets Retreat
Key PointsSpace travel is turning into a huge growth opportunity because of demand for satellites and other payloads.
(RTTNews) - CrowdStrike Holdings, Inc. (CRWD), a cybersecurity technology company, said its board has authorized an additional $500 million for its share repurchase program, increasing the total authorization to $1.5…
Weekly Equities Forecast: Delta Air Lines, Levi Strauss, Constellation Brands